Pharma & Biotech News #PharmaBuzz

Weekly News Recap #Phispers

FDA approves Wockhardt's antibiotic for complicated UTIs; Pfizer inks up to US$ 10.5 billion deal with Innovent

This week’s Phispers is full of news about deals and clinical trials emerging out of the recently concluded annual meetin...

Impressions : 772

Lilly buys three vaccine drugmakers in deals worth up to US$ 3.8 bn; FDA approves AbbVie's ultra rare blood cancer drug

Buoyed by the rising sales of its obesity drug, Eli Lilly has been on an acquisition spree this year. The company announced ag...

Impressions : 1488

FDA issues warning letter to Chinese supplier of semaglutide; approves AstraZeneca's new treatment for hypertension

In Phispers this week, the US Food and Drug Administration (FDA) approved AstraZeneca’s first-in-class treatment for hype...

Impressions : 2230

FDA chief Marty Makary resigns after rocky tenure; Italy's Angelini to buy Catalyst Pharma for US$ 4.1 billion

The US Food and Drug Administration (FDA) has seen several high profile exits under the Trump Administration. The most high pro...

Impressions : 1613

Only few entries up to this point, click to access all

Quality Compliance Alerts #Warning!

All News #Library

Generics

Biotech

APIs

Quality

Sciences

Rare Diseases

Others

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass

FDA approves Wockhardt's antibiotic for complicated UTIs; Pfizer inks up to US$ 10.5 billion deal with Innovent

Lilly buys three vaccine drugmakers in deals worth up to US$ 3.8 bn; FDA approves AbbVie's ultra rare blood cancer drug

FDA issues warning letter to Chinese supplier of semaglutide; approves AstraZeneca's new treatment for hypertension

FDA chief Marty Makary resigns after rocky tenure; Italy's Angelini to buy Catalyst Pharma for US$ 4.1 billion

Somerset' Generics Tofacitinib Citrate Receives Approval in US

Sun Pharma' Generics Tofacitinib Citrate Receives Approval in US

Aurobindo Pharma's Generics Tofacitinib Receives Approval in US

Breckenridge's Generics Tofacitinib Receives Approval in US

Lupin's Biologics Ranluspec Receives Approval in US

Amneal's Generics Romidepsin Receives Approval in US

Aurobindo Pharma's Generics Eluxadoline Receives Approval in US

Casper Pharma's Tiocystin Receives Approval in US

Jiangsu Anbison's Generics Cyclosporine Receives Approval in US

Zydus' Generics Fluorescein Na Receives Approval in US

Haleon Issues Voluntary Nationwide Recall of Gas-X Extra Strength

Enforcement Report - Week of June 3, 2026

Medline's Receives FDA Warning Letter

HealthPartners Neuroscience Center's Receives FDA Warning Letter

Aeroflex Industria de Aerosol 's Receives FDA Warning Letter

Laboratorios Jaloma's Receives FDA Warning Letter

Enforcement Report - Week of May 27, 2026

Alchymars ICM SM's Receives FDA Warning Letter

GC America's Receives FDA Warning Letter

Sato's Receives FDA Warning Letter

SynbioTech Launches SYNMUE for Immunosenescence at Probiota

Ractigen Presents saRNA as Obesity Treatment Frontier at ADA'26

Novo's Zenagamtide Achieves 14.6% Weight Loss in T2D at ADA 2026

Grifols Backs AlphaDetect to Speed Alpha-1 Antitrypsin Detection

Lundbeck Presents Positive Phase IIb Data for Bocunebart at AHS

Lupin Receives FDA Approval for Ranluspec (Ranibizumab)

Cabaletta Shares Rese-cel, PC-Free Lupus Data at EULAR

Aurobindo Enters Biologics CDMO with Rs 1,200-Cr Plant

ADC Therapeutics' Ph3: ZYNLONTA + Rituximab Results in r/r DLBCL

Neuronoff Treats 1st Patient in DOD-Fund Injectrode Bladder Trial

Glenmark Enters U.S. Market with Generic Lacosamide Injection

Aurobindo Pharma Gets USFDA Nod for Generic Tofacitinib Tablets

Breckenridge Launches Tofacitinib Tablets, Generic of Xeljanz®

Amneal Receives FDA Approval for Romidepsin Injection Solution

India's Regulatory Landscape Becoming More Globally Aligned

Supreme Court Sides with Hikma in 'Skinny Label' Case

Delhi HC Directs CDSCO on Zydus Semaglutide Safety Concerns

Apotex Launches Sitagliptin Tablets with 180-Day Exclusivity

Lupin and Natco Receive FDA Approval for Eribulin Mesylate

Axsome Settlement Resolving All SUNOSI Patent Litigation

SynbioTech Launches SYNMUE for Immunosenescence at Probiota

Ractigen Presents saRNA as Obesity Treatment Frontier at ADA'26

Novo's Zenagamtide Achieves 14.6% Weight Loss in T2D at ADA 2026

Lundbeck Presents Positive Phase IIb Data for Bocunebart at AHS

Lupin Receives FDA Approval for Ranluspec (Ranibizumab)

Cabaletta Shares Rese-cel, PC-Free Lupus Data at EULAR

Aurobindo Enters Biologics CDMO with Rs 1,200-Cr Plant

ADC Therapeutics' Ph3: ZYNLONTA + Rituximab Results in r/r DLBCL

Race for a Bundibugyo Ebola Vaccine: From Failure to Preparedness

How Biotech Companies Are Surviving and Thriving With DEI Efforts

TDB Supports Indigenous Production of Green Pharma Ingredients

PharmaBlock's First Peptide GMP Pilot Plant Now Operational

Niner Pharma Expands Global Peptide and Oncology API Network

Intracin Pharma Gets Australian APVMA Approval for Vet Medicines

NPPA Revises Injectable Antibiotic Price Ceiling Following Review

The Power of Micronization in Small Molecule APIs

India-Oman CEPA Kicks Off June 1 with Zero Pharma Tariffs

Wockhardt Gets CDSCO Nod for Zaynich Antibiotic

CordenPharma Strikes Peptide CDMO Deal for US and China Sites

True North Buys 25% Stake In Pharma co Embio

CDSCO Logs 1,387 Adverse Drug Reaction Reports in 9Months of 2025

DCGI Demands Strict Revised Schedule M Compliance at Pharmac Expo

CDSCO Orders All Stakeholders to Set Up Pharmacovigilance Systems

FDA Issues Warning to Drugmaker for Misleading Email Promotion

Teva UK Issues Class 4 Defect Notification for Ponlimsi Denosumab

ADC Therapeutics' Shares Plummet After Patient Deaths in Trial

China BioCrackdown Calls Draw Growing Pushback in Washington

Roche Chairman Accuses US Gov of Drug Price 'Blackmail'

Industry Concerned Over Traceability Expansion Pace

Novo Nordisk Indiana Site Under FDA Scrutiny Again

Neuronoff Treats 1st Patient in DOD-Fund Injectrode Bladder Trial

Lung Cancer Detection in Brazil Is Changing Patient Outcomes

Us Domestic Treatment Centers Ready for Ebola Even as Kenya Plans